Literature DB >> 26315518

Colorectal Cancer Screening.

Kjetil Garborg1.   

Abstract

Colorectal cancer (CRC) is a leading cause of cancer morbidity and mortality in the Western world. Advances in surgical and medical management have led to improved outcomes; however, the prognosis of CRC is often poor when detected at a symptomatic stage. Most cases of CRC develop over years from removable well-defined precursor lesions, and asymptomatic, curable disease may be detected by convenient noninvasive tests. These features make CRC a suitable candidate for screening, and several options are available. This article outlines the evidence for established CRC screening tests along with a discussion on newer tests and ongoing research.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenoma; Colonoscopy; Colorectal cancer; Prevention; Screening

Mesh:

Substances:

Year:  2015        PMID: 26315518     DOI: 10.1016/j.suc.2015.05.007

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  13 in total

1.  The role of interleukin-8 (CXCL8) and CXCR2 in acquired chemoresistance of human colorectal carcinoma cells HCT116.

Authors:  Daiva Dabkeviciene; Violeta Jonusiene; Vilmante Zitkute; Egle Zalyte; Pranas Grigaitis; Vida Kirveliene; Ausra Sasnauskiene
Journal:  Med Oncol       Date:  2015-10-30       Impact factor: 3.064

Review 2.  The efficacy of autofluorescence imaging in the diagnosis of colorectal diseases.

Authors:  Kentaro Moriichi; Mikihiro Fujiya; Toshikatsu Okumura
Journal:  Clin J Gastroenterol       Date:  2016-06-13

Review 3.  Role of Urinary Biomarkers in the Diagnosis of Adenoma and Colorectal Cancer: A Systematic Review and Meta-Analysis.

Authors:  Emma Altobelli; Paolo Matteo Angeletti; Giovanni Latella
Journal:  J Cancer       Date:  2016-10-08       Impact factor: 4.207

4.  Identification of a specific peptide binding to colon cancer cells from a phage-displayed peptide library.

Authors:  Lidan Hou; Danxi Zhu; Yu Liang; Xiaohui Tian; Lei Li; Ping Wang; Liming Zhu; Xiaoling Weng; Yingying Wang; Yue Li; Tianqi Wu; Jianhua Wang; Xiangjun Meng
Journal:  Br J Cancer       Date:  2017-10-24       Impact factor: 7.640

5.  An Ethanolic Extract of Ampelopsis Radix Exerts Anti-colorectal Cancer Effects and Potently Inhibits STAT3 Signaling In Vitro.

Authors:  Tao Su; Jing-Xuan Bai; Ying-Jie Chen; Xin-Ning Wang; Xiu-Qiong Fu; Ting Li; Hui Guo; Pei-Li Zhu; Yue Wang; Zhi-Ling Yu
Journal:  Front Pharmacol       Date:  2017-04-28       Impact factor: 5.810

6.  Comprehensive investigation of a novel differentially expressed lncRNA expression profile signature to assess the survival of patients with colorectal adenocarcinoma.

Authors:  Jiang-Hui Zeng; Liang Liang; Rong-Quan He; Rui-Xue Tang; Xiao-Yong Cai; Jun-Qiang Chen; Dian-Zhong Luo; Gang Chen
Journal:  Oncotarget       Date:  2017-03-07

7.  Salidroside could enhance the cytotoxic effect of L‑OHP on colorectal cancer cells.

Authors:  Xiaoming Shi; Wei Zhao; Yongbin Yang; Shengchun Wu; Bonan Lv
Journal:  Mol Med Rep       Date:  2017-10-20       Impact factor: 2.952

8.  Monitoring colorectal cancer following surgery using plasma circulating tumor DNA.

Authors:  Xiao Sun; Tanxiao Huang; Fangsheng Cheng; Kaibing Huang; Ming Liu; Wan He; Mingwei Li; Xiaoni Zhang; Mingyan Xu; Shifu Chen; Ligang Xia
Journal:  Oncol Lett       Date:  2018-01-22       Impact factor: 2.967

9.  Filamin A interacting protein 1-like expression inhibits progression in colorectal cancer.

Authors:  Young-Lan Park; Sun-Young Park; Seung-Hyun Lee; Rul-Bin Kim; Joong-Keun Kim; Sung-Yoon Rew; Dae-Seong Myung; Sung-Bum Cho; Wan-Sik Lee; Hyun-Soo Kim; Young-Eun Joo
Journal:  Oncotarget       Date:  2016-11-01

10.  Diagnostic and prognostic values of C‑X‑C motif chemokine ligand 3 in patients with colon cancer.

Authors:  Guo-Tian Ruan; Yi-Zhen Gong; Xi-Wen Liao; Shuai Wang; Wei Huang; Xiang-Kun Wang; Guang-Zhi Zhu; Cun Liao; Feng Gao
Journal:  Oncol Rep       Date:  2019-09-19       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.